Healthcare - Biotechnology - NASDAQ - US
$ 0.8335
-3.45 %
$ 38 M
Market Cap
-0.45
P/E
Price Target
Average
1387.70%
Revenue Forecast
Estimate
118.98%
EBIT
Estimate
22.63%
Net Income
Estimate
19.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verrica Pharmaceuticals Inc.
Wall Street analysts predict an average 1-year price target for VRCA of $12.4 , with forecasts ranging from a low of $10 to a high of $14 .
VRCA Lowest Price Target
Wall Street Target
10 USD
1099.76%
VRCA Average Price Target
Wall Street Target
12.4 USD
1387.70%
VRCA Highest Price Target
Wall Street Target
14 USD
1579.66%
REVENUE FORECAST
Revenue Forecast Chart VRCA
EBIT FORECAST
EBIT Forecast Chart VRCA
NET INCOME FORECAST
Net Income Chart VRCA